Home > Boards > US Listed > Biotechs >

MyoKardia, Inc. (MYOK)

Add MYOK Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 8/24/2017 6:42:21 PM - Followers: 3 - Board type: Free - Posts Today: 0

MyoKardia, Inc. 333 Allerton Avenue South San Francisco, CA 94080 United States Phone: 650-741-0900 Website: http://www.myokardia.com MyoKardia, Inc., a clinical stage biopharmaceutical company, engages in discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is MYK-461, a small molecule that is in three Phase I clinical trials designed to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy (HCM). The company also develops DCM-1, a drug compound that treats heritable dilated cardiomyopathy (DCM) by restoring normal contractility in the diseased DCM heart. In addition, it develops HCM-2, a product candidate to reduce cardiac muscle contractility to normal levels in HCM patients; and LUS-1, a product candidate, which is intended to counteract a muscle disruption that results in impaired relaxation of the heart. The company has a strategic collaboration with Sanofi S.A. MyoKardia, Inc. was founded in 2012 and is headquartered in South San Francisco, California.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MYOK News: MyoKardia Appoints William Fairey as Chief Commercial Officer 01/23/2019 08:30:00 AM
MYOK News: MyoKardia to Present at 37th Annual J.P. Morgan Healthcare Conference 01/03/2019 08:00:00 AM
MYOK News: Current Report Filing (8-k) 01/02/2019 04:19:03 PM
MYOK News: MyoKardia Regains Global Rights to Mavacamten and MYK-491 Programs from Sanofi 01/02/2019 08:00:00 AM
MYOK News: MyoKardia Reports Positive Data from Phase 1b Single-Ascending Dose Clinical Trial of MYK-491 in Dilated Cardiomyopathy and S... 12/11/2018 08:30:00 AM
News News Alert: MyoKardia Appoints William Fairey as Chief Commercial Officer 01/23/2019 08:30:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#15   MYOK is total Junk they pumped it up rqtect 08/24/17 06:42:21 PM
#14   Sanofi stepping up Whalatane 08/16/17 09:42:46 PM
#13   Bernstein Whalatane 08/11/17 09:51:35 AM
#12   $1.2 BILLION for a one trick pony junk Bernstein 08/11/17 08:36:48 AM
#11   Berstein ..actually you are way off on MYOK. Whalatane 08/10/17 10:52:07 PM
#10   $1.2 BILLION Bubble /most advanced drug is in Bernstein 08/09/17 02:07:52 PM
#9   https://seekingalpha.com/article/4096485-myokardia-gets-root-problem Inoviorulez 08/08/17 05:13:14 PM
#8   https://www.advfn.com/news_Prospectus-Filed-Pursuant-to-Rule-424b5-424b5_7540308 ADVFN_njmustang123 08/08/17 03:16:06 PM
#7   Offering Coming :( stock1ace1 08/08/17 08:56:54 AM
#6   Amazing, such a legit corp. with awesome management expediter13 08/07/17 06:48:45 PM
#5   FANTASTIC short opp created today on ridiculous phase Bernstein 08/07/17 01:22:57 PM
#4   Partner Fund Management, L.P. has filed a new wiltonio 04/13/17 04:08:57 PM
#3   Here’s What To Look For Ahead Of The venturecapp 07/12/16 01:15:12 PM
#2   Great biotech stock thanks for the tip! Eric33psc 06/17/16 08:36:18 PM
#1   MYOK bullish 14.40 stocktrademan 06/16/16 02:24:25 PM